When it comes to cancer, we aren't afraid of a challenge. Utilizing our cell-driven biologics, we aim to overcome longstanding cancer treatment hurdles & ultimately transform lives.

Our team of experts is driven to make an impact, as we aspire to improve patient outcomes through innovative cell-based therapies.

 

Advisory Board

 
Khalid+Shah+Circle+Headshot.png

Khalid Shah

Vice Chairman of Research, BWH-Neurosurgery

Director, Center for Stem Cell Therapeutics and Imaging

Associate Professor, Harvard Medical School

Principal Faculty, Harvard Stem Cell Institute in Boston

Gerhard+Bauer+Circle+Headshot.png

Gerhard Bauer

Professor of Hematology and Oncology, Director of the Good Manufacturing Practice (GMP) Laboratory, UC Davis Institute for Regenerative Cures

Dr+Antonio+E+Chiocca+Circle+Headshot.png

Antonio E. Chiocca

Chairman Neurosurgery, Brigham and Women’s Hospital

Harvey Cushing Professor of Neurosurgery, Harvard Medical School

Brock+Reeve+Circle+Headshot.png

Brock Reeve

Executive Director, Harvard Stem Cell Institute

 
 
 
Imran+Nasrullah+Circle+Headshot.png

Imran Nasrullah

Director, BD&L, Strategic Partnering, Boehringer Ingelheim

Glenn+Prestwich+Circle+Headshot.png

Glenn D. Prestwich

Presidential Professor of Medicinal Chemistry, Presidential Special Assistant for Faculty Entrepreneurism, University of Utah

Founder of the Entrepreneurial Faculty Scholars Program, University of Utah

Arthur+Hiller+Circle+Headshot.png

Arthur Hiller

CEO, Strategic Consultant and Business Advisor, Start-Up Companies